These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 240024)

  • 21. The population-dependent requirement by cultured mammalian cells for metabolites which they can synthesize. II. Glutamic acid and glutamine; aspartic acid and asparagine.
    Eagle H; Washington CL; Levy M; Cohen L
    J Biol Chem; 1966 Nov; 241(21):4994-9. PubMed ID: 4288834
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
    Kiriyama Y; Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H
    Leukemia; 1989 Apr; 3(4):294-7. PubMed ID: 2564453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of rat liver asparagine synthetase by Cibacron Blue F3GA.
    Hongo S; Sato T
    Enzyme; 1984; 31(3):181-6. PubMed ID: 6145587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells.
    Broome JD
    J Exp Med; 1968 Jun; 127(6):1055-72. PubMed ID: 4871211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion.
    Zhang J; Fan J; Venneti S; Cross JR; Takagi T; Bhinder B; Djaballah H; Kanai M; Cheng EH; Judkins AR; Pawel B; Baggs J; Cherry S; Rabinowitz JD; Thompson CB
    Mol Cell; 2014 Oct; 56(2):205-218. PubMed ID: 25242145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamine inhibits the ammonia-dependent activities of two Cys-1 mutants of human asparagine synthetase through the formation of an abortive complex.
    Sheng S; Moraga-Amador DA; van Heeke G; Allison RD; Richards NG; Schuster SM
    J Biol Chem; 1993 Aug; 268(22):16771-80. PubMed ID: 8102140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the control of asparagine biosynthesis in mammalian tissues.
    Patterson MK
    Recent Results Cancer Res; 1970; 33():22-30. PubMed ID: 5526344
    [No Abstract]   [Full Text] [Related]  

  • 28. The regulation of L-asparaginase activity in rats and mice. Effects of normal and malignant growth, of sex and of dietary changes.
    Bonetti E; Abbondanza A; Della Corte E; Stirpe F
    Biochem J; 1969 Nov; 115(3):597-601. PubMed ID: 4311065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of total nitrogen, asparagine, and glutamine on MCA tumor growth in the Fischer 344 rat.
    Popp MB; Enrione EB; Wagner SC; Chance WT
    Surgery; 1988 Aug; 104(2):152-60. PubMed ID: 2899915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DON, CONV and DONV-II. Inhibition of L-'asparagine synthetase in vivo.
    Rosenbluth RJ; Cooney DA; Jayaram HN; Milman HA; Homan ER
    Biochem Pharmacol; 1976 Aug; 25(16):1851-8. PubMed ID: 9091
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethacrynic acid--an inhibitor of L-asparagine synthetase.
    Jayaram HN; Cooney DA; Milman HA; Homan ER; King WM; Cragoe EJ
    Biochem Pharmacol; 1975 Oct; 24(19):1787-92. PubMed ID: 9943
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypersensitivity of rat glioma sublines with acquired ACNU resistance to L-asparaginase.
    Saito Y; Nakada Y; Hotta T; Mikami T; Kurisu K; Kiya K; Kawamoto K; Uozumi T
    J Neurosurg; 1991 Dec; 75(6):930-4. PubMed ID: 1682427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminomalonic acid and its congeners as potential in vivo inhibitors of L-asparagine synthetase.
    Milman HA; Muth R; Cooney DA
    Enzyme; 1979; 24(1):36-47. PubMed ID: 35346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
    Aslanian AM; Kilberg MS
    Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of L-asparaginase and the effects of host and enzyme modification.
    Uren JR
    Cancer Treat Rep; 1981; 65 Suppl 4():47-55. PubMed ID: 6125260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and properties of asparagine synthetase from rat liver.
    Hongo S; Matsumoto T; Sato T
    Biochim Biophys Acta; 1978 Jan; 522(1):258-66. PubMed ID: 23163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some properties of L-asparagine synthetase of the L-asparaginase-resistant mouse lymphoma 6C3HED [proceedings].
    Davies MR; Marshall RD
    Biochem Soc Trans; 1979 Feb; 7(1):174-6. PubMed ID: 35419
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of L-asparagine synthetase by mineral cations.
    Milman HA; Cooney DA; Ward JM
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):573-80. PubMed ID: 42170
    [No Abstract]   [Full Text] [Related]  

  • 39. Kinetic mechanism of asparagine synthetase from Vibrio cholerae.
    Fresquet V; Thoden JB; Holden HM; Raushel FM
    Bioorg Chem; 2004 Apr; 32(2):63-75. PubMed ID: 14990305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-Asparagine synthetase in serum as a marker for neoplasia.
    Cooney DA; King VD; Cable RG; Taylor B; Wodinsky I
    Cancer Res; 1976 Sep; 36(9 pt.1):3238-45. PubMed ID: 10081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.